Urology
Volume 75, Issue 2 , Pages 393-398 , February 2010

Impact of Comorbidity on Survival of Invasive Bladder Cancer Patients, 1996-2007: A Danish Population-based Cohort Study

  • Lars Lund

      Affiliations

    • Department of Urology, Viborg Hospital 8800, Viborg, Denmark
    • Center for Health Services Research, Vanderbilt University Medical Center, Nashville, Tennessee
    • Corresponding Author InformationReprint requests: L. Lund, M.D., Department of Urology, Viborg Hospital 8800, Viborg, Denmark
    • ,
  • Jacob Jacobsen

      Affiliations

    • Department of Clinical Epidemiology, Aarhus University Hospital 8000, Aarhus C, Denmark
    • ,
  • Peter Clark

      Affiliations

    • Department of Urology, Vanderbilt University Hospital, Nashville, Tennessee
    • ,
  • Michael Borre

      Affiliations

    • Department of Urology, Skejby University Hospital 8210, Aarhus N, Denmark
    • ,
  • Mette Nørgaard

      Affiliations

    • Center for Health Services Research, Vanderbilt University Medical Center, Nashville, Tennessee
    • Department of Clinical Epidemiology, Aarhus University Hospital 8000, Aarhus C, Denmark
    • ,
  • Northern Danish Cancer Quality Assessment Group

Received 16 March 2009 ,Accepted 28 July 2009.

References 

  1. National Board of Health. Cancer Incidence in Denmark 2000. Copenhagen, Denmark: National Board of Health 204; 2004;
  2. US Bureau of the Census. UDoC Projections of the Population of the United States by Age, Sex and Race, 1988-2080 (Current Population Reports, Population Estimates and Projections Series No 1018). Washington, DC: Government Printing Office; 1991;
  3. Clark PE, Stein JP, Groshen SG, et al. Radical cystectomy in the elderly: comparison of survival between younger and older patients. Cancer. 2005;103:546–552
  4. Konety BR, Joslyn SA. Factors influencing aggressive therapy for bladder cancer: an analysis of data from the SEER program. J Urol. 2003;170:1765–1771
  5. Coleman MP, Gatta G, Verdecchia A, et al. EUROCARE-3 summary: cancer survival in Europa at the end of the 20th century. Ann Oncol. 2003;14:128–149
  6. Andersen TF, Madsen M, Jorgensen J, et al. The Danish National Hospital Register (A valuable source of data for modern health sciences). Dan Med Bull. 1999;46:263–268
  7. Tetsche MS, Nørgaard M, Skriver MV, et al. Accuracy of ovarian cancer ICD-10 diagnosis in a Danish population-based hospital discharge registry. Eur J Gynaecol Oncol. 2005;26:266–270
  8. Frank L. Epidemiology (When an entire country is a cohort). Science. 2000;287:2398–2399
  9. Charlson ME, Pompei P, Ales KL, et al. A new method of classifying prognostic comorbidity in longitudinal studies: development and validation. J Chronic Dis. 1987;40:373–383
  10. Sorensen HT. Regional administrative health registers as a resource in clinical epidemiology (A study of options, strengths, limitations and data quality provided with examples of use). Int J Risk Saf Med. 1997;10:1–22
  11. Koppie TM, Serio AM, Vickers AJ, et al. Age-adjusted Charlson comorbidity score is associated with treatment decisions and clinical outcomes for patients undergoing radical cystectomy for bladder cancer. Cancer. 2008;112:2384–2395
  12. Lowrance WT, Rumohr JA, Chang SS, et al. Contemporary open radical cystectomy: analysis of perioperative outcomes. J Urol. 2008;179:1313–1318
  13. Prout GR, Wesley MN, Yancik R, et al. Age and comorbidity impact surgical therapy in older bladder carcinoma patients (A population-based study). Cancer. 2005;104:1638–1647
  14. Yancik R, Havlik RJ, Wesley MN, et al. Cancer and comorbidity in older patients: a descriptive profile. Ann Epidemiol. 1996;6:399–412
  15. Sackett DL, Haynes RB, Guyatt GH, et al. Clinical Epidemiology: A Basic Science for Clinical Medicine. 2nd ed.. Boston, MA: Little, Brown; 1991;
  16. Konety BR, Allareddy V, Carroll PR. Factors affecting outcomes after radical cystectomy in African Americans. Cancer. 2007;100:542–548
  17. Wallace DM, Bryan RT, Dunn JA, et al. Delay and survival in bladder cancer. BJU Int. 2002;89:868–878
  18. Miller DC, Taub DA, Dunn RL, et al. The impact of co-morbid disease on cancer control and survival following radical cystectomy. J Urol. 2003;169:105–109
  19. Shelley MD, Wilt TJ, Barber J, et al. A meta-analysis of randomised trials suggests a survival benefit for combined radiotherapy and radical cystectomy compared with radical radiotherapy for invasive bladder cancer: are these data relevant to modern practice?. Clin Oncol. 2004;16:166–171
  20. Shariat SF, Karakiewicz PI, Palapattu GS, et al. Nomograms provide improved accuracy for predicting survival after radical cystectomy. Clin Cancer Res. 2006;12:6663–6676

 The study was supported by the Western Danish Research Forum for Health Sciences.

 Other members of the Northern Danish Cancer Quality Assessment group: Tove Nilsson, Lars Dal Pedersen, Poul Bartels, Hendrik Vilstrup, Hans Peder Graversen, Anna Birthe Bach, Peder Graversen, and Erik Højkær Larsen.

PII: S0090-4295(09)02473-X

doi: 10.1016/j.urology.2009.07.1320

Urology
Volume 75, Issue 2 , Pages 393-398 , February 2010

Article Tools

* Image Usage & Resolution